Inventor · disambiguated record
Paul H. Weinreb
Also filed as: WEINREB PAUL H · WEINREB PAUL HENRY · Weinreb Paul
22 granted patents·12 pending applications·232 citations·filing 2000–2024
95Inventor score
Files withBIOGEN MA INC9KINIKSA PHARMACEUTICALS LTD7BIOGEN IDEC INC6BIOGEN INT NEUROSCIENCE GMBH5VIOLETTE SHELIA M3
Top patents by PatentIndex Score
34 records- 0194US7943742B2Anti-αvβ6 antibodies and uses thereofBIOGEN IDEC INC·Filed 2006·Granted May 17, 2011·29 cites·14 claims
- 0294US7465449B2Anti-αvβ6 antibodiesBIOGEN IDEC INC·Filed 2003·Granted Dec 16, 2008·71 cites·58 claims
- 0393US9598484B2Human anti-tau antibodiesBIOGEN MA INC·Filed 2013·Granted Mar 21, 2017·18 cites·182 claims
- 0491US8153126B2Anti-αvβ6 antibodiesVIOLETTE SHELIA M·Filed 2008·Granted Apr 10, 2012·25 cites·16 claims
- 0589US9580493B2Anti-α synuclein binding moleculesWEIHOFEN ANDREAS·Filed 2012·Granted Feb 28, 2017·16 cites·58 claims
- 0689US2025230250A1Oncostatin m receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 0788US9593163B2Oncostatin M receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2016·Granted Mar 14, 2017·5 cites·16 claims
- 0887US8669345B2Nogo receptor antagonistsLEE DANIEL H S·Filed 2007·Granted Mar 11, 2014·16 cites·3 claims
- 0987US6897297B1Hydrophobically-modified protein compositions and methodsBIOGEN IDEC INC·Filed 2000·Granted May 24, 2005·21 cites·51 claims
- 1086US10259866B2TDP-43 specific binding moleculesBIOGEN INT NEUROSCIENCE GMBH·Filed 2016·Granted Apr 16, 2019·7 cites·88 claims
- 1185US10301381B2Anti-alpha synuclein binding moleculesBIOGEN INT NEUROSCIENCE GMBH·Filed 2018·Granted May 28, 2019·4 cites·16 claims
- 1284US9975947B2Anti-alpha synuclein binding moleculesBIOGEN INT NEUROSCIENCE GMBH·Filed 2017·Granted May 22, 2018·4 cites·15 claims
- 1384US9587014B2TDP-43 specific binding moleculesBIOGEN INT NEUROSCIENCE GMBH·Filed 2012·Granted Mar 7, 2017·7 cites·33 claims
- 1481US9663571B2Oncostatin M receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2014·Granted May 30, 2017·3 cites·16 claims
- 1578US12122837B2Oncostatin M receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2021·Granted Oct 22, 2024·0 cites·28 claims
- 1678US10421813B2Oncostatin M receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2017·Granted Sep 24, 2019·1 cites·12 claims
- 1777US9738721B1Oncostatin M receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2017·Granted Aug 22, 2017·1 cites·16 claims
- 1876US9228015B2Nogo receptor antagonists and methods of increasing neurite outgrowthBIOGEN IDEC INC·Filed 2014·Granted Jan 5, 2016·2 cites·5 claims
- 1973US9745376B2Anti-ανβ6 antibodiesBIOGEN MA INC·Filed 2014·Granted Aug 29, 2017·1 cites·8 claims
- 2072US2020262895A1Human anti-tau antibodiesBIOGEN MA INC·Filed 2019·Application pending·0 cites
- 2169US11091540B2TDP-43 specific binding moleculesBIOGEN INT NEUROSCIENCE GMBH·Filed 2019·Granted Aug 17, 2021·0 cites·31 claims
- 2268US8992924B2Anti-ανβ6 antibodies and uses thereofVIOLETTE SHELIA M·Filed 2011·Granted Mar 31, 2015·1 cites·43 claims
- 2368US2009054632A1Hydrophobically-modified protein compositions and methodsBIOGEN IDEC INC·Filed 2007·Application pending·0 cites
- 2468US2019359724A1Oncostatin m receptor antigen binding proteinsKINIKSA PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 2563US2005119181A1Hydrophobically-modified protein compositions and methodsCURIS INC·Filed 2004·Application pending·0 cites
- 2659US2019169274A1Human anti-tau antibodiesBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 2756US2014294809A1Anti-Alpha(v)Beta(6) Antibodies and Uses ThereofBIOGEN IDEC INC·Filed 2014·Application pending·0 cites
- 2855US2017369560A1Human anti-tau antibodiesBIOGEN MA INC·Filed 2017·Application pending·0 cites
- 2953US2012251532A1Anti-alpha v beta 6 antibodiesVIOLETTE SHELIA M·Filed 2012·Application pending·0 cites
- 3050US10035860B2Anti-alpha V beta 6 antibodies and uses thereofBIOGEN MA INC·Filed 2014·Granted Jul 31, 2018·0 cites·21 claims
- 3148US2016159878A1NOGO Receptor AntagonistsBIOGEN MA INC·Filed 2015·Application pending·0 cites
- 3246US10035859B2Anti-alpha V beta 6 antibodies and uses thereofBIOGEN MA INC·Filed 2014·Granted Jul 31, 2018·0 cites·21 claims
- 3337US2015315267A1A method of reducing brain amyloid plaques using anti-ab antibodiesBUSSIERE THIERRY·Filed 2013·Application pending·0 cites
- 3431US2017362324A1Humanized anti-alpha v beta 5 antibodies and uses thereofBIOGEN MA INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul H. Weinreb files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →